P
Palisade Bio D
D
PALI
2.40000
USD
-0.21
(-8.05%)
Market Open
Volume
154
EPS
0
Div Yield
0
P/E
-0
Market Cap
2,842,769
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news
More
Title: Palisade Bio
Sector: Healthcare
Industry: Biotechnology
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.